Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol
出版年份 2019 全文链接
标题
Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol
作者
关键词
Olaparib, Phase I, Children, Solid tumor, Chemotherapy, Poly(ADP-ribose) polymerase
出版物
BMC Pediatrics
Volume 19, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-01-26
DOI
10.1186/s12887-019-1409-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- EWS–FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma
- (2018) Aparna Gorthi et al. NATURE
- Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Minimum Age Working Group
- (2017) Lia Gore et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor
- (2017) Masatoshi Takagi et al. JNCI-Journal of the National Cancer Institute
- Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor
- (2017) Masatoshi Takagi et al. JNCI-Journal of the National Cancer Institute
- Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours
- (2016) Kan Yonemori et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib
- (2016) J. Mateo et al. Targeted Oncology
- Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics
- (2016) Florian Engert et al. Oncotarget
- Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer
- (2015) Yung-Jue Bang et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Post-relapse survival in patients with Ewing sarcoma
- (2015) Stefano Ferrari et al. PEDIATRIC BLOOD & CANCER
- Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
- (2015) Michal Kovac et al. Nature Communications
- Targeting the DNA Repair Pathway in Ewing Sarcoma
- (2014) Elizabeth Stewart et al. Cell Reports
- Relapses in hepatoblastoma patients: Clinical characteristics and outcome – Experience of the International Childhood Liver Tumour Strategy Group (SIOPEL)
- (2012) M. Semeraro et al. EUROPEAN JOURNAL OF CANCER
- Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project
- (2011) Wendy B. London et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry
- (2009) Alberto Garaventa et al. EUROPEAN JOURNAL OF CANCER
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
- (2008) S. Rottenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation